- Home
- RVPHW vs NYMTN Comparison
RVPHW vs NYMTN Comparison
Compare RVPHW & NYMTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- NYMTN
- Stock Information
- Founded
- RVPHW N/A
- NYMTN N/A
- Country
- RVPHW United States
- NYMTN United States
- Employees
- RVPHW 15
- NYMTN 79
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- NYMTN Real Estate Investment Trusts
- Sector
- RVPHW Health Care
- NYMTN Real Estate
- Exchange
- RVPHW Nasdaq
- NYMTN Nasdaq
- Market Cap
- RVPHW N/A
- NYMTN N/A
- IPO Year
- RVPHW 2018
- NYMTN N/A
- Fundamental
- Price
- RVPHW $0.18
- NYMTN $22.36
- Analyst Decision
- RVPHW
- NYMTN
- Analyst Count
- RVPHW 0
- NYMTN 0
- Target Price
- RVPHW N/A
- NYMTN N/A
- AVG Volume (30 Days)
- RVPHW N/A
- NYMTN N/A
- Earning Date
- RVPHW N/A
- NYMTN N/A
- Dividend Yield
- RVPHW N/A
- NYMTN N/A
- EPS Growth
- RVPHW N/A
- NYMTN N/A
- EPS
- RVPHW N/A
- NYMTN N/A
- Revenue
- RVPHW N/A
- NYMTN N/A
- Revenue This Year
- RVPHW N/A
- NYMTN N/A
- Revenue Next Year
- RVPHW N/A
- NYMTN N/A
- P/E Ratio
- RVPHW N/A
- NYMTN N/A
- Revenue Growth
- RVPHW N/A
- NYMTN N/A
- 52 Week Low
- RVPHW N/A
- NYMTN N/A
- 52 Week High
- RVPHW N/A
- NYMTN N/A
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- NYMTN 31.10
- Support Level
- RVPHW N/A
- NYMTN $21.97
- Resistance Level
- RVPHW N/A
- NYMTN $22.60
- Average True Range (ATR)
- RVPHW 0.00
- NYMTN 0.20
- MACD
- RVPHW 0.00
- NYMTN -0.05
- Stochastic Oscillator
- RVPHW 0.00
- NYMTN 8.79
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About NYMTN New York Mortgage Trust Inc. 8.00% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.